Clinical Toxicology · 2018 · 26 citations · 11 references
Life SciencesImmunologyPharmacologyAllergyHypersensitivityPediatric AllergyAllergic ConditionsAllergic DiseaseAnaphylaxisDrug AllergyVenom AllergyAntivenom DosingAntivenom ReactionsCohort Study InvestigationDelayed Hypersensitivity ReactionsDrug Hypersensitivity ReactionsLoading Dose MonitoringPediatric Venom AllergyVenom Allergy In Adults
CONTEXT: The administration of Crotalidae polyvalent immune Fab (FabAV) currently requires close observation, so patients can be monitored for hypersensitivity reactions. The objective of this study was to evaluate the occurrence of hypersensitivity reactions to FabAV. METHOD: This was a retrospective cohort study utilizing data from a statewide poison center database in the United States. Records of all patients envenomated by a rattlesnake and treated with FabAV between January 2002 and December 2014 were evaluated. Patients with acute hypersensitivity reactions were identified, and reactions were evaluated descriptively. RESULTS: A total of 1340 adult and pediatric patients received FabAV during the study period. Of these, 19 (1.4%) patients had a potential reaction to FabAV, with 10 requiring a reduction in infusion rate, but none requiring discontinuation of the antivenom. Reactions occurred during the loading dose (n = 10), maintenance doses (n = 4), or were delayed reactions (n = 6). Symptoms recorded included pruritus (n = 8), hives (n = 8), rash (n = 7), vomiting (n = 7), nausea (n = 6), dyspnea or wheezing (n = 4), diaphoresis (n = 3), throat irritation (n = 2), and mild hypotension (n = 2). One patient was given a concomitant administration of low dose epinephrine infusion until completion of the antivenom course. However, none of the reactions were considered to be life-threatening. CONCLUSION: FabAV appears to be associated with a low incidence of acute hypersensitivity reactions. Patients may not require placement in a location capable of detecting and rapidly responding to hemodynamic and/or airway issues for FabAV monitoring alone.
11
Anuradhani Kasturiratne, A.R. Wickremasinghe, Nilanthi de Silva et al. · PLoS Medicine · 2008 · 1.9K citations · Full text
Public Health, Health Sciences, Population Health Sciences +16
Eric J. Lavonas, Anne‐Michelle Ruha, William Banner et al. · BMC Emergency Medicine · 2011 · 235 citations · Full text
Richard C. Dart, Steven A. Seifert, Leslie Boyer et al. · Archives of Internal Medicine · 2001 · 221 citations
Venomous snakebites in the United States: management review and update.
Gregory Juckett, John G. Hancox · PubMed · 2002 · 150 citations
Pharmacy, Hematology, Toxicology +15